Medicenna Therapeutics Corp. (TSX:MDNA)
0.4700
0.00 (0.00%)
Sep 4, 2026, 2:09 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 43.38 million as of September 4, 2026. Its market cap has decreased by -49.99% in one year.
Market Cap
43.38M
Enterprise Value
37.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
ChartMarket Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 65.63M to 43.38M, a decrease of -33.90%. That is a compound annual growth rate of -4.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 43.38M | -43.47% |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| Sona Nanotech | 44.21M |
| Sernova Biotherapeutics | 43.43M |
| BriaCell Therapeutics | 43.06M |
| Telescope Innovations | 40.42M |
| Microbix Biosystems | 39.72M |
| Defence Therapeutics | 37.89M |
| Onco-Innovations | 37.57M |